ASC40

· Ascletis Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ASC40, covering 2024-10-31 to 2025-12-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris [Phase 3]